HDAC3 and lung adenocarcinoma: Lastly, quantification of HDAC-3 mRNA in tissue specimens of 94 lung adenocarcinoma patients revealed its correlation with clinicopathologic parameters, suggesting a significantly poorer prognosis in patients overexpressing HDAC-3 isoform [56].